McMurray, J. J., Young, J. B., Dunlap, M. E., Granger, C. B., Hainer, J. W., Michelson, E. L., … Pfeffer, M. A. (2006). Candesartan improves outcome in patients with low ejection fraction heart failure, irrespective of background dose of ACE inhibitor: An analysis of the CHARM-added trial. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 47, pp. 52A-52A).

McMurray, J. J., J. B. Young, M. E. Dunlap, C. B. Granger, J. W. Hainer, E. L. Michelson, S. Earle, et al. “Candesartan improves outcome in patients with low ejection fraction heart failure, irrespective of background dose of ACE inhibitor: An analysis of the CHARM-added trial.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 47:52A-52A, 2006.

McMurray JJ, Young JB, Dunlap ME, Granger CB, Hainer JW, Michelson EL, et al. Candesartan improves outcome in patients with low ejection fraction heart failure, irrespective of background dose of ACE inhibitor: An analysis of the CHARM-added trial. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2006. p. 52A-52A.

McMurray, J. J., et al. “Candesartan improves outcome in patients with low ejection fraction heart failure, irrespective of background dose of ACE inhibitor: An analysis of the CHARM-added trial.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 47, no. 4, 2006, pp. 52A-52A.

McMurray JJ, Young JB, Dunlap ME, Granger CB, Hainer JW, Michelson EL, Earle S, Olofsson B, Ostergren J, Yusuf S, Swedberg K, Pfeffer MA. Candesartan improves outcome in patients with low ejection fraction heart failure, irrespective of background dose of ACE inhibitor: An analysis of the CHARM-added trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2006. p. 52A-52A.